Banner Health

Banner Health was paid $18.21M by Medicaid between Aug 2018 and Dec 2024, across 156 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	15,275	$873K
2019	40,978	$3.15M
2020	34,284	$2.62M
2021	43,716	$3.05M
2022	50,278	$3.24M
2023	48,671	$2.94M
2024incomplete	38,756	$2.33M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	24%	11,874	10,592	$4.32M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	21%	7,970	6,942	$3.89M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	19%	10,434	9,549	$3.50M
74177	Computed tomography, abdomen and pelvis; with contrast material	10%	2,115	1,983	$1.85M
74176	Computed tomography, abdomen and pelvis; without contrast material	7.3%	1,960	1,823	$1.34M
70450	Computed tomography, head or brain; without contrast material	3.9%	3,049	2,798	$718K
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.6%	3,185	2,919	$653K
72125	Computed tomography, cervical spine; without contrast material	2.3%	961	905	$421K
G0378	Hospital observation service, per hour	1.5%	1,417	712	$271K
71275	Computed tomographic angiography, chest, with contrast material	1.1%	312	300	$195K
71046	Radiologic examination, chest; 2 views	<1%	2,738	2,554	$113K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	565	554	$96K

144 more codes

76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	449	$69K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,415	$64K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	3,945	$58K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,179	$51K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	3,966	$44K
73562		<1%	900	$39K
J2704	Injection, propofol, 10 mg	<1%	2,868	$33K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	8,668	$31K
73030		<1%	904	$31K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	14	$30K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	4,015	$29K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	487	$29K
99213	Doctor's office visit, returning patient (routine)	<1%	78	$24K
71250		<1%	101	$20K
74018		<1%	458	$17K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,663	$16K
93971		<1%	165	$16K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	24	$16K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	331	$14K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	51	$13K
72131		<1%	41	$13K
72100		<1%	67	$13K
59025	Fetal non-stress test	<1%	338	$12K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	68	$11K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	43	$10K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	45	$9K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,755	$9K
96375	Therapeutic injection; each additional sequential IV push	<1%	7,041	$9K
80320		<1%	2,526	$8K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	56	$8K
71045	Radiologic examination, chest; single view	<1%	6,366	$8K
80053	Comprehensive metabolic panel	<1%	16,555	$7K
73630		<1%	284	$7K
73502		<1%	189	$7K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	12	$7K
77080		<1%	66	$6K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	8,086	$6K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	12	$5K
73610		<1%	359	$5K
73130		<1%	282	$5K
J3490	Unclassified drugs	<1%	10,839	$4K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	29	$4K
87631		<1%	804	$4K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	257	$3K
80048	Basic metabolic panel (calcium, ionized)	<1%	2,768	$3K
72110		<1%	12	$3K
76830	Ultrasound, transvaginal	<1%	256	$3K
76801		<1%	27	$3K
73110		<1%	78	$2K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	3,362	$2K
84702		<1%	1,015	$1K
84443	Thyroid stimulating hormone (TSH)	<1%	841	$751.72
A9270	Non-covered item or service	<1%	10,429	$689.63
86850		<1%	170	$591.35
83880		<1%	1,782	$514.13
94760		<1%	563	$363.42
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,422	$338.67
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	17,013	$330.88
87186		<1%	747	$233.27
86769		<1%	196	$199.90
87077		<1%	1,073	$197.34
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,604	$173.27
87040		<1%	1,950	$142.42
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,241	$126.06
85027		<1%	2,037	$118.20
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	6,854	$113.10
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,113	$108.63
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	675	$102.62
81001		<1%	6,110	$99.92
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,471	$94.53
83690		<1%	4,941	$93.14
82947		<1%	3,840	$67.47
81025		<1%	1,771	$54.06
83735		<1%	2,160	$47.42
84484		<1%	7,513	$47.13
83605		<1%	3,581	$39.64
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,132	$35.71
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	698	$34.21
36415	Collection of venous blood by venipuncture	<1%	100	$23.78
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,448	$19.10
81003		<1%	3,144	$16.07
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	7,949	$15.87
85014		<1%	31	$15.68
J0690	Injection, cefazolin sodium, 500 mg	<1%	466	$15.48
85379		<1%	393	$12.32
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,099	$10.71
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	5,005	$10.68
85610		<1%	2,572	$7.43
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,037	$7.32
84703		<1%	1,029	$4.81
85007		<1%	100	$2.71
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	105	$0.00
86900		0%	214	$0.00
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	0%	493	$0.00
96367		0%	217	$0.00
J2550	Injection, promethazine hcl, up to 50 mg	0%	769	$0.00
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	0%	40	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	985	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	13	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	55	$0.00
90715		0%	182	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	54	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	130	$0.00
80076		0%	14	$0.00
82565		0%	26	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	52	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	25	$0.00
84520		0%	27	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	23	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	33	$0.00
85055		0%	14	$0.00
87088		0%	2,029	$0.00
96376		0%	2,091	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	179	$0.00
85730		0%	553	$0.00
J7999	Compounded drug, not otherwise classified	0%	208	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	998	$0.00
86901		0%	246	$0.00
J8597	Antiemetic drug, oral, not otherwise specified	0%	584	$0.00
73090		0%	14	$0.00
Q0247	Injection, sotrovimab, 500 mg	0%	16	$0.00
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	0%	201	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	614	$0.00
J2060	Injection, lorazepam, 2 mg	0%	709	$0.00
80329		0%	114	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	71	$0.00
J1815	Injection, insulin, per 5 units	0%	74	$0.00
86140		0%	608	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	52	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	99	$0.00
87807		0%	133	$0.00
87081		0%	151	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	20	$0.00
J0456	Injection, azithromycin, 500 mg	0%	14	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	105	$0.00
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	0%	224	$0.00
82550		0%	45	$0.00
85018		0%	31	$0.00
82270		0%	12	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	18	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	16	$0.00
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	0%	31	$0.00
96368		0%	16	$0.00
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSKABELAND, HOYT (CEO)

Parent organizationBANNER HEALTH